discusses both companies' earnings results, with Eli Lilly seeing strong sales of its GLP-1 drugs Mounjaro and Zepbound. Khemlani also takes a look at some of the other pharmaceutical companies in the GLP-1 space.Another trending story that we are watching here in the health care space G LP one, a key driver of the broader health care space.This earning season, companies like Eli Lily and no, no showing the demand for weight loss treatments does remain strong.
Pfizer, however, has been slowing down its prospects decreasing as it ran into some trouble with its drug, the oral GP one that it is now in clinical trials with it still figuring out the dosing for its one daily and it had a that didn't have good tolerability.Meanwhile, Amgen, moving ahead with its once monthly potentially injectable, that's in phase two and going to be going to phase three trial soon.
After one of the most exciting games in United States men's basketball history, Kevin Durant was awake early in the morning. The late Kobe Bryant, who was Durant's teammate the 2012 London Olympics, used to discuss the Antoniette Costa Reveals She Underwent Brain Surgery: 'There Was a Risk That I Wouldn't Be Able to Sing Again'
Portugal Últimas Notícias, Portugal Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Fonte: YahooFinanceCA - 🏆 47. / 63 Consulte Mais informação »